Jeremy M Levin - Net Worth and Insider Trading
Jeremy M Levin Net Worth
The estimated net worth of Jeremy M Levin is at least $6 Million dollars as of 2024-11-05. Jeremy M Levin is the CEO of Ovid Therapeutics Inc and owns about 3,652,176 shares of Ovid Therapeutics Inc (OVID) stock worth over $4 Million. Jeremy M Levin is also the SVP Strat Transactions of Bristol-Myers Squibb Co and owns about 20,505 shares of Bristol-Myers Squibb Co (BMY) stock worth over $1 Million. Details can be seen in Jeremy M Levin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeremy M Levin has not made any transactions after 2024-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jeremy M Levin
Jeremy M Levin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jeremy M Levin owns 2 companies in total, including Ovid Therapeutics Inc (OVID) , and Bristol-Myers Squibb Co (BMY) .
Click here to see the complete history of Jeremy M Levin’s form 4 insider trades.
Insider Ownership Summary of Jeremy M Levin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2024-03-18 | director & 10 percent owner & CEO |
| BMY | Bristol-Myers Squibb Co | 2010-05-04 | SVP Strat Transactions |
Jeremy M Levin Latest Holdings Summary
Jeremy M Levin currently owns a total of 2 stocks. Among these stocks, Jeremy M Levin owns 3,652,176 shares of Ovid Therapeutics Inc (OVID) as of March 18, 2024, with a value of $4 Million and a weighting of 79.61%. Jeremy M Levin also owns 20,505 shares of Bristol-Myers Squibb Co (BMY) as of May 4, 2010, with a value of $1 Million and a weighting of 20.39%.
Latest Holdings of Jeremy M Levin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc | 2024-03-18 | 3,652,176 | 1.23 | 4,492,176 |
| BMY | Bristol-Myers Squibb Co | 2010-05-04 | 20,505 | 56.11 | 1,150,433 |
Holding Weightings of Jeremy M Levin
Jeremy M Levin Form 4 Trading Tracker
According to the SEC Form 4 filings, Jeremy M Levin has made a total of 2 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Ovid Therapeutics Inc is the acquisition of 18,248 shares on March 18, 2024, which cost Jeremy M Levin around $50,365.
According to the SEC Form 4 filings, Jeremy M Levin has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 0 shares on May 4, 2010, which brought Jeremy M Levin around $0.
Insider Trading History of Jeremy M Levin
- 1
Jeremy M Levin Trading Performance
GuruFocus tracks the stock performance after each of Jeremy M Levin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeremy M Levin is 7.52%. GuruFocus also compares Jeremy M Levin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeremy M Levin within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jeremy M Levin's insider trading performs compared to the benchmark.
Performance of Jeremy M Levin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.61 | | | | | |
| Relative Return to S&P 500(%) | 10.12 | | | | | |
Jeremy M Levin Ownership Network
Ownership Network List of Jeremy M Levin
Ownership Network Relation of Jeremy M Levin
Jeremy M Levin Owned Company Details
What does Ovid Therapeutics Inc do?
Who are the key executives at Ovid Therapeutics Inc?
Jeremy M Levin is the director & 10 percent owner & CEO of Ovid Therapeutics Inc. Other key executives at Ovid Therapeutics Inc include Chief Commercial Officer Jason Tardio , 10 percent owner Takeda Pharmaceuticals U.s.a., Inc. , and CMO and PMO Amit Rakhit .
Ovid Therapeutics Inc (OVID) Insider Trades Summary
Over the past 18 months, Jeremy M Levin made 1 insider transaction in Ovid Therapeutics Inc (OVID) with a net purchase of 18,248.
In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.
Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ovid Therapeutics Inc Insider Transactions
Jeremy M Levin Mailing Address
Above is the net worth, insider trading, and ownership report for Jeremy M Levin. Currently GuruFocus does not have mailing address information for Jeremy M Levin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
